Cargando…

Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli serotype O55:H7 in England, 2014–2018

Recurrent outbreaks of haemolytic uraemic syndrome (HUS) caused by Shiga toxin-producing Escherichia coli (STEC) serotype O55:H7 occurred in England between 2014 and 2018. We reviewed the epidemiological evidence to identify potential source(s) and transmission routes of the pathogen, and to assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawyer, C., Vishram, B., Jenkins, C., Jorgensen, F., Byrne, L., Mikhail, A. F. W., Dallman, T. J., Carroll, K., Ahyow, L., Vahora, Q., Godbole, G., Balasegaram, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161408/ https://www.ncbi.nlm.nih.gov/pubmed/33866980 http://dx.doi.org/10.1017/S0950268821000844

Ejemplares similares

Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England
por: Jenkins, Claire, et al.
Publicado: (2020)

The emerging importance of Shiga toxin-producing Escherichia coli other than serogroup O157 in England
por: Vishram, Bhavita, et al.
Publicado: (2021)

Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study
por: Byrne, Lisa, et al.
Publicado: (2023)

Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
por: Walsh, Patrick R., et al.
Publicado: (2018)

Recurrent seasonal outbreak of an emerging serotype of Shiga toxin-producing Escherichia coli (STEC O55:H7 Stx2a) in the south west of England, July 2014 to September 2015
por: McFarland, Noëleen, et al.
Publicado: (2017)

Cutaneous involvement in haemolytic uraemic syndrome
por: Neild, G. H., et al.
Publicado: (2013)

Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017)

Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed
por: Karpman, Diana
Publicado: (2012)

Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report
por: Bally, Stéphane, et al.
Publicado: (2019)

Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential
por: Dowen, Frances, et al.
Publicado: (2017)

Eculizumab and drug-induced haemolytic–uraemic syndrome
por: Faguer, Stanislas, et al.
Publicado: (2013)

Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009–2012
por: Launders, N, et al.
Publicado: (2016)

Phylogenetic context of Shiga toxin-producing Escherichia coli serotype O26:H11 in England
por: Dallman, Timothy J., et al.
Publicado: (2021)

Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992–2013
por: Naseer, U., et al.
Publicado: (2017)

The haemolytic-uraemic syndrome. A report of two cases.
por: Field, C. M., et al.
Publicado: (1965)

Haemolytic-Uraemic Syndrome as a Sequela of Diarrhoeal Disease
por: Walker, Christa L. Fischer, et al.
Publicado: (2012)

Early treatment with eculizumab in atypical haemolytic uraemic syndrome
por: Garjau, Maria, et al.
Publicado: (2012)

A case of lethal enteroviral haemolytic uraemic syndrome?
por: Afzal, Shoaib, et al.
Publicado: (2008)

Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021)

Evolutionary Context of Non–Sorbitol-Fermenting Shiga Toxin–Producing Escherichia coli O55:H7
por: Schutz, Kyle, et al.
Publicado: (2017)

Psychiatric Symptoms in Patients with Shiga Toxin-Producing E. coli O104:H4 Induced Haemolytic-Uraemic Syndrome
por: Kleimann, Alexandra, et al.
Publicado: (2014)

Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
por: Adams, Natalie, et al.
Publicado: (2019)

The epidemiology of Shiga toxin-producing Escherichia coli serogroup O157 in England, 2009–2019
por: Butt, Saira, et al.
Publicado: (2022)

Outcome of atypical haemolytic uraemic syndrome relapse after eculizumab withdrawal
por: Duineveld, Caroline, et al.
Publicado: (2020)

Recent advances in diagnosis and treatment of atypical haemolytic uraemic syndrome
por: Bolton-Maggs, Paula HB
Publicado: (2010)

Complement therapy in atypical haemolytic uraemic syndrome (aHUS)
por: Wong, Edwin K.S., et al.
Publicado: (2013)

Leptospirosis presenting as haemolytic uraemic syndrome: a case report
por: Muthuppalaniappan, Vasantha Muthu, et al.
Publicado: (2018)

Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021)

Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021)

Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016
por: Bruyand, Mathias, et al.
Publicado: (2019)

Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
por: Venables, Julian P, et al.
Publicado: (2006)

L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)
por: Kanzelmeyer, Nele Kirsten, et al.
Publicado: (2014)

Haemolytic uraemic syndrome associated with H1N1 influenza
por: Farinha, Ana, et al.
Publicado: (2010)

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome
por: Macia, Manuel, et al.
Publicado: (2017)

The difficult distinction between haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura
por: Thachil, Jecko
Publicado: (2008)

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
por: Gómez Delgado, Irene, et al.
Publicado: (2021)

AZD-1222: Atypical haemolytic uraemic syndrome recurrence: case report
Publicado: (2022)

Shiga toxin-producing Escherichia coli O26:H11 associated with a cluster of haemolytic uraemic syndrome cases in South Africa, 2017
por: Smith, Anthony M., et al.
Publicado: (2019)

Highly Pathogenic Clone of Shiga Toxin–Producing Escherichia coli O157:H7, England and Wales
por: Byrne, Lisa, et al.
Publicado: (2018)

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_67a6p06dcnjpjtdd8t48np6n6f